The advanced course in Risk Management
Webcode 26012050
Dr. Martin Huber
-requested- Senior Expert Pharmacovigilance, Bonn, GERMANY
Senior Expert Pharmacovigilance German PRAC member
Anika Staack
ARC-Traicoa UG, Überlingen, GERMANY
Founder and PV Expert,
Consultant, EU-QPPV and local QPPV;
Anika Staack serves as EU-QPPV and local QPPV. In this role, she is responsible for establishing and maintaining of pharmacovigilance systems as well as ensuring compliance and meeting quality standards of PV operations. She acts as contact point for regulatory authorities in regards to PV and also for PV inspections. Anika has held positions of increasing responsibility for the past 15 years in the pharmaceutical industry, with extensive experience in the clinical research operations sector. Anika holds a Master of Science degree in biology from Marburg University.
More information please click here.
Dr. Tiziana von Bruchhausen
Boehringer Ingelheim International, Ingelheim, GERMANY
Principal Pharmacovigilance Writer;
Dr Tiziana von Bruchhausen began her career in pharmacovigilance in 2008. Over the years, she has worked as a pharmacovigilance writer for mid-sized and large pharmaceutical companies, held various roles in contract research organisations, and worked as a freelance safety writer.
Currently serving as Principal Pharmacovigilance Writer at Boehringer Ingelheim, her responsibilities encompass both pre- and post-submission activities. These include global strategic planning and the preparation of key PV documents such as RMPs, PSURs, or DSURs.
Dr von Bruchhausen is also an active member of the European Medical Writers Association (EMWA). Since 2017, she has chaired the Pharmacovigilance Special Interest Group Committee. Additionally, she served as EMWA's President elect from 2017 to 2019.
More information please click here.
29/01/2026
29/01/2026
09:00-17:00 CET
You may dial in 30 min before the session
online
online
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 1,290 € zzgl. MwSt.
The participation fee includes documentation for download, a certificate, access to the Learning Space and technical support including PreMeeting.
Nadja Wolff
Conference Manager
+49 6221 500-696
n.wolff@forum-institut.de
Do you already have a good understanding of PSUR and RMP including risk minimisation measures and would like to deepen, broaden and update your knowledge? Then this course is for you! Learn about pharmacovigilance requirements in the drug lifecycle and their impact on RMP and PSUR from a global perspective. Save your place now!
This seminar deepens your knowledge in RMP and PSUR preparation, assessment and regulatory management.
The updated GVP Module XVI - Risk minimisation measures (Rev 3) came into force on 6 August 2024. The FORUM Institute and our speakers guarantee that we will incorporate all updates into the training in an understandable way!
By attending this seminar, you will refresh your knowledge of the current European guidelines according to EMA Modules V and XVI. You will also learn new aspects of safety concerns and best practices for additional risk minimisation measures.
Take a look at pharmacovigilance documents from a QPPV perspective and benefit from our speakers' many years of experience with global authorities or in writing and harmonising RMP and PSUR!
After completing the online seminar, you will
08:45
09:00
09:15
Dr Tiziana von Bruchhausen
09:45
Dr Tiziana von Bruchhausen, Dr Martin Huber
10:30 Break
10:45
Dr Tiziana von Bruchhausen, Dr Martin Huber
11:15
Anika Staack
11:45
Dr Martin Huber
12:15 Break
13:15
Dr Tiziana von Bruchhausen
13:45
Anika Staack
14:15
Anika Staack
15:00 Break
15:15
Dr Martin Huber
16:00
Anika Staack
16:45
All speakers
17:00 Seminar ends
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
The Good Pharmacovigilance Practices modules (GVP modules) by the European Medicines Agency (EMA) serve as a reference f...
This online training offers comprehensive insights into Regulatory Affairs, CMC, and GMP requirements, with a focus on t...
Join our interactive course to explore how AI is transforming pharmacovigilance. Take part in discussions, hands-on work...
The compact course with a content focus on the development, production and analytics of biotech drugs. Secure your place...
This course familiarises you with regulatory post-approval duties and provides first-hand information on variation submi...
Necessary PV documents, contents and a medical writing checklist as a short overview.
Details
Many abbreviations are used in all regulatory areas. Download the list of the most important ones.
Details
We are now officially certified to ISO 9001 and ISO 21001 standard.
Details
Comments of participants (March 2020)
Since I am relatively new to the field, I wanted to learn more about RMP and PSUR life cycle management in general. I learned many things that I can use for my daily work. The seminar met my expectations.
My expectations were to have an open discussion on these matters and to check if we, as a company, are aligned with the other companies. these were fully met.
My initial expectations were about the identification of the important safety concerns according to the new GVP module V rev.2 and the identification of the additional PV activities and their possible effectiveness measures. All topics were discussed with a high level of detail.
The interaction between speakers and the content; was very lively.
The great interactions.
This is what participants in (November 2018) liked most about the event.
Topics, interactive presentations.
